Literature DB >> 26566648

Advances in Microbiology, Infectious Diseases and Public Health: Refractory Trichophyton rubrum Infections in Turin, Italy: A Problem Still Present.

Vivian Tullio1, Ornella Cervetti2, Janira Roana1, Michele Panzone3, Daniela Scalas1, Chiara Merlino1, Valeria Allizond1, Giuliana Banche1, Narcisa Mandras1, Anna Maria Cuffini4.   

Abstract

Dermatophytosis caused by Trichophyton rubrum is the most common cutaneous fungal infection in industrialized countries and worldwide with high recurrence and lack of treatment response. In addition, patients with cutaneous and concurrent toenail lesions are often misdiagnosed and therefore treated with an inappropriate therapy. In this study, we evaluated five previously misdiagnosed cases of T.rubrum chronic dermatophytosis sustained by two variants at sites distant from the primary lesion. Our patients were successfully treated by systemic and topical therapy, and 1 year after the end of therapy follow-up did not show any recurrence of infection.Our data indicate that the localization of all lesions, the isolation and the identification of the causative fungus are essential to establish the diagnosis and the setting of a correct therapeutic treatment to avoid recurrences.

Entities:  

Keywords:  Chronic dermatophytosis; Misdiagnosis; Trichophyton rubrum

Mesh:

Year:  2016        PMID: 26566648     DOI: 10.1007/5584_2015_5012

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  A case report of tinea capitis in infant in first year of life.

Authors:  Narcisa Mandras; Janira Roana; Ornella Cervetti; Michele Panzone; Vivian Tullio
Journal:  BMC Pediatr       Date:  2019-02-22       Impact factor: 2.125

2.  Antifungal Activity of Melaleuca alternifolia Essential Oil (TTO) and Its Synergy with Itraconazole or Ketoconazole against Trichophyton rubrum.

Authors:  Janira Roana; Narcisa Mandras; Daniela Scalas; Paolo Campagna; Vivian Tullio
Journal:  Molecules       Date:  2021-01-17       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.